Non-Coding RNA (Mar 2019)
Catalyzing Transcriptomics Research in Cardiovascular Disease: The CardioRNA COST Action CA17129
- Clarissa Pedrosa da Costa Gomes,
- Bence Ágg,
- Andrejaana Andova,
- Serdal Arslan,
- Andrew Baker,
- Monika Barteková,
- Dimitris Beis,
- Fay Betsou,
- Stephanie Bezzina Wettinger,
- Branko Bugarski,
- Gianluigi Condorelli,
- Gustavo José Justo da Silva,
- Sabrina Danilin,
- David de Gonzalo-Calvo,
- Alfonso Buil,
- Maria Carmo-Fonseca,
- Francisco J. Enguita,
- Kyriacos Felekkis,
- Peter Ferdinandy,
- Mariann Gyöngyösi,
- Matthias Hackl,
- Kanita Karaduzovic-Hadziabdic,
- Jan Hellemans,
- Stephane Heymans,
- Markéta Hlavackova,
- Morten Andre Hoydal,
- Aleksandra Jankovic,
- Amela Jusic,
- Dimitris Kardassis,
- Risto Kerkelä,
- Gabriela M. Kuster,
- Päivi Lakkisto,
- Przemyslaw Leszek,
- Mitja Lustrek,
- Lars Maegdefessel,
- Fabio Martelli,
- Susana Novella,
- Timothy O’Brien,
- Christos Papaneophytou,
- Thierry Pedrazzini,
- Florence Pinet,
- Octavian Popescu,
- Ines Potočnjak,
- Emma Robinson,
- Shlomo Sasson,
- Markus Scholz,
- Maya Simionescu,
- Monika Stoll,
- Zoltan V. Varga,
- Manlio Vinciguerra,
- Angela Xuereb,
- Mehmet Birhan Yilmaz,
- Costanza Emanueli,
- Yvan Devaux
Affiliations
- Clarissa Pedrosa da Costa Gomes
- Cardiovascular Research Unit, Luxembourg Institute of Health, L-1445 Strassen, Luxembourg
- Bence Ágg
- Department of Pharmacology and Pharmacotherapy, Semmelweis University, 1085 Budapest, Hungary
- Andrejaana Andova
- Department of Intelligent Systems, Jozef Stefan Institute, 1000e Ljubljana, Slovenia
- Serdal Arslan
- Department of Medical Biology, Faculty of Medicine, Cumhuriyet University, 58140 Sivas, Turkey
- Andrew Baker
- Centre for Cardiovascular Science, The Queen’s Medical Research Institute, University of Edinburgh, Edinburgh EH16 4TJ, UK
- Monika Barteková
- Institute for Heart Research, Centre of Experimental Medicine, Slovak Academy of Sciences, 84104 Bratislava, Slovakia
- Dimitris Beis
- Biomedical Research Foundation, Academy of Athens, 11527 Athens, Greece
- Fay Betsou
- Integrated BioBank of Luxembourg, L-3550 Dudelange, Luxembourg
- Stephanie Bezzina Wettinger
- Faculty of Health Sciences, University of Malta, MSD 2080 Msida, Malta
- Branko Bugarski
- Faculty of Technology and Metallurgy, University of Belgrade, 11000 Belgrade, Serbia
- Gianluigi Condorelli
- Department Cardiovascular, Humanitas Research Hospital, 20089 Rozzano, Italy
- Gustavo José Justo da Silva
- Institute for Experimental Medical Research, Oslo University Hospital and University of Oslo, PB 4956 Nydalen, NO-0424 Oslo, Norway
- Sabrina Danilin
- Firalis, 68330 Huningue, France
- David de Gonzalo-Calvo
- Institute of Biomedical Research of Barcelona (IIBB)—Spanish National Research Council (CSIC), 08036 Barcelona, Spain
- Alfonso Buil
- Mental Health Center Sct. Hans, 4000 Roskilde, Denmark
- Maria Carmo-Fonseca
- Instituto de Medicina Molecular, Faculty Medicine, University Lisboa, 1649-028 Lisboa, Portugal
- Francisco J. Enguita
- Instituto de Medicina Molecular, Faculty Medicine, University Lisboa, 1649-028 Lisboa, Portugal
- Kyriacos Felekkis
- Department of Life and Health Sciences, School of Sciences and Engineering, University of Nicosia, 2417 Nicosia, Cyprus
- Peter Ferdinandy
- Department of Pharmacology and Pharmacotherapy, Semmelweis University, 1085 Budapest, Hungary
- Mariann Gyöngyösi
- Department of Cardiology, Medical University of Vienna, 1090 Vienna, Austria
- Matthias Hackl
- TAmiRNA, 1190 Vienna, Austria
- Kanita Karaduzovic-Hadziabdic
- Faculty of Engineering and Natural Sciences, International University of Sarajevo, 71210 Sarajevo, Bosnia and Herzegovina
- Jan Hellemans
- Biogazelle, 9052 Zwijnaarde, Belgium
- Stephane Heymans
- School for Cardiovascular Diseases, Faculty Health, Medicine and Life Sciences, Maastricht University, 6229ER Maastricht, The Netherlands
- Markéta Hlavackova
- Department of Developmental Cardiology, Institute of Physiology of the Czech Academy of Sciences, 142 20 Prague, Czech Republic
- Morten Andre Hoydal
- Department of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences, NTNU Norwegian University of Technology and Science, NO-7489 Trondheim, Norway
- Aleksandra Jankovic
- Department of Physiology, Institute for Biological Research “Siniša Stanković,” University of Belgrade, 11000 Belgrade, Serbia
- Amela Jusic
- Department of Biology, Faculty of Natural Sciences and Mathematics, University of Tuzla, 75000 Tuzla, Bosnia and Herzegovina
- Dimitris Kardassis
- Department of Basic Sciences, University of Crete Medical School and Institute of Molecular Biology and Biotechnology (IMBB), Foundation for Research and Technology of Hellas, Heraklion 71003, Crete, Greece
- Risto Kerkelä
- Research Unit of Biomedicine, University of Oulu, 90014 Oulu, Finland
- Gabriela M. Kuster
- Department of Biomedicine and Clinic of Cardiology, University Hospital and University of Basel, 4031 Basel, Switzerland
- Päivi Lakkisto
- Minerva Institute for Medical Research, 00290 Helsinki, Finland
- Przemyslaw Leszek
- The Cardinal Stefan Wyszynski Institute of Cardiology, 04-628 Warsaw, Poland
- Mitja Lustrek
- Department of Intelligent Systems, Jozef Stefan Institute, 1000e Ljubljana, Slovenia
- Lars Maegdefessel
- Center for Molecular Medicine, Karolinska Institute, 17176 Stockholm, Sweden
- Fabio Martelli
- Molecular Cardiology Laboratory, IRCCS-Policlinico San Donato, 20097 San Donato Milanese, Milan, Italy
- Susana Novella
- Department of Physiology, University of Valencia and INCLIVA Biomedical Research Institute INCLIVA, 46010 Valencia, Spain
- Timothy O’Brien
- Regenerative Medicine Institute REMEDI, National University of Ireland Galway (NUIG), H91 TK33 Galway, Ireland
- Christos Papaneophytou
- Department of Life and Health Sciences, School of Sciences and Engineering, University of Nicosia, 2417 Nicosia, Cyprus
- Thierry Pedrazzini
- Experimental Cardiology Unit, Division of Cardiology, Department of Cardiovascular Medicine, University of Lausanne Medical School, 1011 Lausanne, Switzerland
- Florence Pinet
- INSERM, Institut Pasteur de Lille, 59019 Lille Cedex, France
- Octavian Popescu
- Babes-Bolyai University, 400084 Cluj-Napoca, Romania
- Ines Potočnjak
- University Hospital Centre Sisters of Charity, Institute for clinical medical research and education, 10 000 Zagreb, Croatia
- Emma Robinson
- Department of Cardiology, Centre for Heart Failure Research, Faculty of Health, Medicine and Life Sciences, Maastricht University, 6229 ER Maastricht, The Netherlands
- Shlomo Sasson
- Institute for Drug Research, Faculty of Medicine, The Hebrew University, 91120 Jerusalem, Israel
- Markus Scholz
- Institute for Medical Informatics, Statistics and Epidemiology IMISE, Medical Faculty, University of Leipzig, 04107 Leipzig, Germany
- Maya Simionescu
- Institute of Cellular Biology and Pathology “Nicolae Simionescu”, 050568 Bucharest, Romania
- Monika Stoll
- Westfälische Wilhelms-Universität Münster, Institute of Human Genetics, Department of Genetic Epidemiology, 48149 Münster, Germany
- Zoltan V. Varga
- Department of Pharmacology and Pharmacotherapy, Semmelweis University, 1085 Budapest, Hungary
- Manlio Vinciguerra
- International Clinical Research Center, 656 91 Brno, Czech Republic
- Angela Xuereb
- Faculty of Health Sciences, University of Malta, MSD 2080 Msida, Malta
- Mehmet Birhan Yilmaz
- Dokuz Eylul University, Faculty of Medicine, Department of Cardiology, 35340 Izmir, Turkey
- Costanza Emanueli
- National Heart & Lung Institute, Faculty of Medicine, Imperial College London, London W12 0HH, UK
- Yvan Devaux
- Cardiovascular Research Unit, Luxembourg Institute of Health, L-1445 Strassen, Luxembourg
- DOI
- https://doi.org/10.3390/ncrna5020031
- Journal volume & issue
-
Vol. 5,
no. 2
p. 31
Abstract
Cardiovascular disease (CVD) remains the leading cause of death worldwide and, despite continuous advances, better diagnostic and prognostic tools, as well as therapy, are needed. The human transcriptome, which is the set of all RNA produced in a cell, is much more complex than previously thought and the lack of dialogue between researchers and industrials and consensus on guidelines to generate data make it harder to compare and reproduce results. This European Cooperation in Science and Technology (COST) Action aims to accelerate the understanding of transcriptomics in CVD and further the translation of experimental data into usable applications to improve personalized medicine in this field by creating an interdisciplinary network. It aims to provide opportunities for collaboration between stakeholders from complementary backgrounds, allowing the functions of different RNAs and their interactions to be more rapidly deciphered in the cardiovascular context for translation into the clinic, thus fostering personalized medicine and meeting a current public health challenge. Thus, this Action will advance studies on cardiovascular transcriptomics, generate innovative projects, and consolidate the leadership of European research groups in the field. COST (European Cooperation in Science and Technology) is a funding organization for research and innovation networks (www.cost.eu).
Keywords
- cardiovascular disease
- transcriptomics
- best practices and guidelines
- translational research
- personalized medicine
